Arcutis Biotherapeutics, Inc. ( ARQT) - Key Metrics
ARQT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.99 | $0.11 | $0.10 | $0.10 |
| 2026Q1 | $0.81 | -$0.09 | $0.02 | $0.02 |
| 2025Q4 | $1.01 | $0.14 | $0.20 | $0.20 |
| 2025Q3 | $0.78 | $0.06 | -$0.01 | -$0.01 |
| 2025Q2 | $0.64 | -$0.13 | $0 | $0 |
ARQT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 59.59 |
| 2026Q1 | 0% | -67.47 |
| 2025Q4 | 0% | 51.86 |
| 2025Q3 | 0% | 81.11 |
| 2025Q2 | 0% | -26.96 |
ARQT Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.36% | 0% |
| 2026Q1 | 0.07% | 0% |
| 2025Q4 | 0.70% | 0% |
| 2025Q3 | -0.07% | 0% |
| 2025Q2 | 0.01% | 0% |
ARQT
Price: $26.19
52 week price:
Earnings Per Share: 0.22 USD
P/E Ratio: 119.23
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 827862
Market Capitalization: 3.3 billion